相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid
P. G. Dedes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Breast and Ovarian Cancers: A Survey and Possible Roles for the Cell Surface Heparan Sulfate Proteoglycans
Atsuko Yoneda et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
Renato V. Iozzo et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Syndecan-1 and Syndecan-4 Are Independent Indicators in Breast Carcinoma
Maria E. Lendorf et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2011)
Syndecans as receptors and organizers of the extracellular matrix
Xiaojie Xian et al.
CELL AND TISSUE RESEARCH (2010)
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
Achilleas D. Theocharis et al.
FEBS JOURNAL (2010)
Proteoglycans in health and disease: the multiple roles of syndecan shedding
Tina Manon-Jensen et al.
FEBS JOURNAL (2010)
Prognostic Significance of Stromal Platelet-Derived Growth Factor β-Receptor Expression in Human Breast Cancer
Janna Paulsson et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR β signalling
Marion T. Weigel et al.
CANCER LETTERS (2009)
Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor
Thamara J. Abouantoun et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Glycosaminoglycans and PDGF signaling in mesenchymal cells
Alexandros Zafiropoulos et al.
CONNECTIVE TISSUE RESEARCH (2008)
Estradiol-estrogen receptor: A key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells
Olga Ch. Kousidou et al.
MOLECULAR ONCOLOGY (2008)
Comprehensive Dissection of PDGF-PDGFR Signaling Pathways in PDGFR Genetically Defined Cells
Erxi Wu et al.
PLOS ONE (2008)
Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-M-MP2 activation
Xanthi N. Stahtea et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer
A. E. Roussidis et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family
LJ Reigstad et al.
FEBS JOURNAL (2005)
Regulation of PDGF and its receptors in fibrotic diseases
JC Bonner
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
PDGF signaling in cells and mice
M Tallquist et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
PDGF and cardiovascular disease
EW Raines
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma
A Östman
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
c-kit and SCF expression in normal and tumor breast tissue
P Ulivi et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells
TN Mitropoulou et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents
A Pandiella et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Regulation of Raf-Akt cross-talk
K Moelling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
New members of the platelet-derived growth factor family of mitogens
CH Heldin et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
Developmental roles of platelet-derived growth factors
C Betsholtz et al.
BIOESSAYS (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Heparan sulfate proteoglycans in invasion and metastasis
RD Sanderson
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2001)
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571
WL Wang et al.
ONCOGENE (2000)
分享论文
